前沿快讯
聚焦肿瘤与肿瘤类器官最新研究,动态一手掌握。

利用LABEL-seq实现细胞内蛋白丰度、活性、相互作用及药物靶向性的多重分析

Multiplexed profiling of intracellular protein abundance, activity, interactions and druggability with LABEL-seq

DOI 原文链接
用sci-hub下载
ℹ️
如无法下载,请从 Sci-Hub 选择可用站点尝试。
影响因子:32.1
分区:生物学1区 Top / 生化研究方法1区
发表日期:2024 Nov
作者: Jessica J Simon, Douglas M Fowler, Dustin J Maly
DOI: 10.1038/s41592-024-02456-7

摘要

本文介绍了LABEL-seq(带有条形码的标记与富集测序技术),一种用于高通量池化蛋白变异体分析的测序方法。通过利用RNA结合域(RBD)自组装形成稳定的变异体编码RNA条形码,LABEL-seq能够直接测量蛋白的性质和功能,采用简单的亲和富集技术对RBD融合蛋白进行富集,然后进行高通量测序以获得共同富集的条形码。对约1,600个BRaf变异体的2万余个变异效应的测定显示,在癌症中频繁突变的位点,变异对蛋白内在丰度影响有限,但对活性、蛋白质相互作用和药物靶向性可能产生巨大影响。整合分析揭示了具有相似生化作用的位点网络,并建立了变异体对细胞增殖和小分子促降解的模型。因此,LABEL-seq实现了在原生细胞环境中直接测量多种生物化学性质,为研究蛋白功能、疾病机制和药物靶向提供了有力工具。

Abstract

Here we describe labeling with barcodes and enrichment for biochemical analysis by sequencing (LABEL-seq), an assay for massively parallel profiling of pooled protein variants in human cells. By leveraging the intracellular self-assembly of an RNA-binding domain (RBD) with a stable, variant-encoding RNA barcode, LABEL-seq facilitates the direct measurement of protein properties and functions using simple affinity enrichments of RBD protein fusions, followed by high-throughput sequencing of co-enriched barcodes. Measurement of ~20,000 variant effects for ~1,600 BRaf variants revealed that variation at positions frequently mutated in cancer minimally impacted intracellular abundance but could dramatically alter activity, protein-protein interactions and druggability. Integrative analysis identified networks of positions with similar biochemical roles and enabled modeling of variant effects on cell proliferation and small molecule-promoted degradation. Thus, LABEL-seq enables direct measurement of multiple biochemical properties in a native cellular context, providing insights into protein function, disease mechanisms and druggability.